A Study of FCN-338 in Patients With Chronic CLL/SLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
- Status
- RECRUITING
- Phase
- PHASE2
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SARS-CoV-2 Donor-Recipient Immunity Transfer
- Status
- COMPLETED
- Phase
- N/A
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
- Status
- WITHDRAWN
- Phase
- PHASE2
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
- Status
- RECRUITING
- Phase
- NA
Early Intervention With Acalabrutinib in Patients With High Risk CLL
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients
- Status
- UNKNOWN
- Phase
- NA
FT819 in Subjects With B-cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A
Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
- Status
- TERMINATED
- Phase
- NA
ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL
- Status
- UNKNOWN
- Phase
- PHASE3
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
- Status
- TERMINATED
- Phase
- PHASE1
The clonoSEQ® Watch Registry
- Status
- TERMINATED
- Phase
- N/A
Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2